The expression of CD33 isoforms is regulated by a single nucleotide polymorphisms, the CC genotype, associated with the expression of CD33M isoform, and is a favorable prognostic factor for Mylotarg therapy in AML (28). This evidence concerns the gene CD33 and acute myeloid leukemia.